413 filings
Page 4 of 21
8-K
ss3gkap
3 Aug 22
Kintara Therapeutics Enters Into Equity Purchase Agreement for Up to $20 Million with Lincoln Park Capital
4:06pm
424B5
jh0cdf
3 Aug 22
Prospectus supplement for primary offering
9:07am
8-K
g559nuzfof06e
22 Jun 22
Amendments to Articles of Incorporation or Bylaws
4:15pm
8-K
o93qi2h gdl61v
16 Jun 22
Kintara Therapeutics Granted Fast Track Designation from the FDA for VAL-083 for Newly-Diagnosed Glioblastoma
9:00am
8-K
27stw3 y2
3 Jun 22
Kintara Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement
9:16am
8-K
ld58a87pss6pvbny7nj3
24 May 22
Departure of Directors or Certain Officers
8:31am
8-K
mad4cvbr7
13 May 22
Kintara Therapeutics Announces Fiscal 2022 Third Quarter Financial Results and Provides Corporate Update
8:15am
DEFA14A
obyzbxebjt pz
6 May 22
Additional proxy soliciting materials
4:10pm
8-K
37co76nhx15j7vy
18 Apr 22
Amendments to Articles of Incorporation or Bylaws
4:37pm
424B5
jfs3eami4aobobdfc7
13 Apr 22
Prospectus supplement for primary offering
4:16pm
8-K
kjy rgze4c9n72up20
13 Apr 22
Kintara Announces $8.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:15pm
8-K
gmi cfh7lie2qw
11 Feb 22
Kintara Therapeutics Announces Fiscal 2022 Second Quarter Financial Results and Provides Corporate Update
8:30am
8-K
3zwagie m54c
8 Feb 22
Departure of Directors or Certain Officers
4:05pm
8-K
v4sk4ni
18 Jan 22
Other Events
4:26pm
8-K
623czchd54479d7af
10 Jan 22
Other Events
7:17am